ProCE Banner Activity

Activity of Antibody Drug Conjugates in NSCLC Clinical Trials

Slideset Download
Download this slideset to gain expert insight into the activity of antibody-drug conjugates within the clinical trial setting for NSCLC.

Released: February 16, 2021

Expiration: February 15, 2022

Share

Faculty

Joel W. Neal

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California